JOURNAL OF THE CZECH PEDIATRIC SOCIETY AND THE SLOVAK PEDIATRIC SOCIETY

Čes-slov Pediat 2024, 79(88):21-24 | DOI: 10.55095/CSPediatrie2024/030

Prevention options of pneumococcal disease in children

Hana Cabrnochová
Očkovací centrum pro děti, Pediatrická klinika, 1. lékařská fakulta, Univerzita Karlova a Fakultní Thomayerova nemocnice, Praha

Pneumococcal infections are

still an important cause of morbidity and mortality in children in the Czech Republic. The risk of pneumococcal infections and their complications depends on age and the presence of chronic diseases. The incidence of invasive pneumococcal disease in children is highest in infancy and gradually decreases with age. Even though vaccination has been introduced, there are still isolated child deaths.

Since 2010, when reimbursed vaccination of infants was introduced, there has been a temporary decrease in vaccination coverage. Over the last period analyzed, an increase in vaccination coverage to 78% was recorded for children born in 2022. Since the introduction of reimbursed vaccination, multi-valent vaccines have been gradually registered, the reimbursement of which has not been fully

reimbursed and a supplemental payment was required for these vaccines.

This year, another conjugate vaccine for children is entering our market, and at the same time, thanks to a change in legislation, all available vaccines against pneumococcal infections in children, including risk groups, are fully reimbursed.

Keywords: invasive pneumococcal disease, pneumococcal vaccines, immunization schedule, risk groups in children, vaccination coverage

Accepted: May 7, 2024; Published: August 1, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cabrnochová H. Prevention options of pneumococcal disease in children. Ces-slov Pediat. 2024;79(Suppl.1):21-24. doi: 10.55095/CSPediatrie2024/030.
Download citation

References

  1. SZÚ. Zprávy CEM. 2023; 32(6-7): 261-266.
  2. Česká vakcinologická společnost ČLS JEP. Doporučení České vakcinologické společnosti ČLS JEP pro očkování dětí a adolescentů ve věku 0-17 let proti pneumokokovým onemocněním. 2024. Dostupné na: https://vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-pro-ockovani-deti-a-adolescentu-ve-veku-0-17-let
  3. Zákon č. 48/1997 Sb., o veřejném zdravotním pojištění a o změně a doplnění některých souvisejících zákonů.
  4. SPC jednotlivých vakcín.Cabrnochová H, Chlíbek R, Dušek L. Proočkovanost u dětí u vybraných preventabilních nákaz za rok 2022 v České republice. Vakcinologie 2023; 17(4): 173-181.
  5. Zákon č. 378/2007 Sb., o léčivech a o změnách některých souvisejících zákonů.
  6. Zákon č. 258/2000 Sb., o ochraně veřejného zdraví a o změnách některých souvisejících zákonů.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.